02/28/2024
3:18 PM | Atea Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
10:35 AM | Atea Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
02/15/2024
8:15 AM | Atea Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
7:02 PM | Atea Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
02/09/2024
7:35 AM | Atea Pharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/07/2024
8:14 AM | Atea Pharmaceuticals (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G | |
02/07/2024
8:25 AM | Atea Pharmaceuticals (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G/A | |
|
02/02/2024
8:26 PM | Atea Pharmaceuticals (Issuer)
Foster Wayne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:29 PM | Atea Pharmaceuticals (Issuer)
Horga Maria Arantxa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:30 PM | Atea Pharmaceuticals (Issuer)
Sommadossi Jean-Pierre (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:31 PM | Atea Pharmaceuticals (Issuer)
Corcoran Andrea (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:24 PM | Atea Pharmaceuticals (Issuer)
Hammond Janet MJ (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:25 PM | Atea Pharmaceuticals (Issuer)
Vavricka John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
8:46 AM | Atea Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
11/28/2023
5:00 AM | Atea Pharmaceuticals (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13D/A | |
11/08/2023
3:15 PM | Atea Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
2:33 PM | Atea Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
10/02/2023
10:45 AM | Atea Pharmaceuticals (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G | |
09/11/2023
7:23 AM | Atea Pharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
06/21/2023
4:02 PM | Atea Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
3:05 PM | Atea Pharmaceuticals (Issuer)
Duncan Barbara Gayle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:05 PM | Adams Jerome M. (Reporting)
Atea Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:05 PM | Atea Pharmaceuticals (Issuer)
Lucidi Bruno (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:05 PM | Atea Pharmaceuticals (Issuer)
BERGER FRANKLIN M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:05 PM | Atea Pharmaceuticals (Issuer)
Polsky Bruce (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:05 PM | Atea Pharmaceuticals (Issuer)
Murphy Polly A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
7:19 AM | Atea Pharmaceuticals (Filer)
| Form DEFA14A | |
05/25/2023
4:22 PM | Atea Pharmaceuticals (Filer)
| Form DEFA14A | |
05/22/2023
8:00 AM | Atea Pharmaceuticals (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13D | |
04/28/2023
3:51 PM | Atea Pharmaceuticals (Filer)
| Form ARS | |
